Adding methylxanthines to standard COPD treatment is not beneficial
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=196376Documentos Relacionados
- To evaluate of the effect of adding licorice to the standard treatment regimen of Helicobacter pylori
- GOLD stage I is not a COPD risk factor
- Vaginal birth after a caesarean is not always beneficial
- Combination treatment may help patients with COPD, but does not improve mortality
- Adding amynoglycoside to β lactam does not improve results